FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:635-638 August 29, 1996 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

In the United States, the hemolytic–uremic syndrome of childhood typically follows gastrointestinal infection with Escherichia coli O157:H7.^1,2,3 It is presumed that the absorption from the gastrointestinal tract of Shiga toxins 1, 2, or both (formerly called Shiga-like toxins⁴) produced by E. coli O157:H7 causes microangiopathic hemolytic anemia as a result of endothelial-cell injury.⁵ Shiga-toxin–producing E. coli belonging to serotypes other than O157:H7 can also cause the hemolytic–uremic syndrome.^5,6 However, even though such organisms have been implicated as causes of sporadic cases⁷ or outbreaks⁸ of gastroenteritis, they are not believed to be important causes of the hemolytic–uremic syndrome in this . . . [Full Text of this Article]

Case Report

Characteristics of the Infecting Strain

Discussion

Source Information

From the Children's Hospital and Medical Center, Seattle (P.I.T., L.S.F., H.H.K., J.C.V., C.R.C.); the Departments of Pediatrics (P.I.T., L.S.F.), Microbiology (P.I.T.), Medicine (A.E.S.), and Laboratory Medicine (C.R.C.), University of Washington School of Medicine, Seattle; and the Department of Veterinary Sciences and the Institute of Molecular Evolutionary Genetics, Pennsylvania State University, University Park (R.A.W.).

Address reprint requests to Dr. Tarr at the Division of Gastroenterology, Mail Stop CH-24, Children's Hospital and Medical Center, 4800 Sand Point Way NE, Seattle, WA 98105.

References

Related Letters:

Escherichia coli and the Hemolytic–Uremic Syndrome
Acheson D. W.K., Wolf L. E., Park C. H., Rossboth D. W., Tarr P. I., Stapleton A. E., Wilson R. A., Rondeau E., Peraldi M.-N.
Extract | Full Text  
N Engl J Med 1997; 336:515-516, Feb 13, 1997. Correspondence

This article has been cited by other articles:

• Karama, M., Johnson, R. P., Holtslander, R., Gyles, C. L. (2008). Phenotypic and Genotypic Characterization of Verotoxin-Producing Escherichia coli O103:H2 Isolates from Cattle and Humans. J. Clin. Microbiol. 46: 3569-3575 [Abstract] [Full Text]  
• Zhang, W., Bielaszewska, M., Pulz, M., Becker, K., Friedrich, A. W., Karch, H., Kuczius, T. (2008). New Immuno-PCR Assay for Detection of Low Concentrations of Shiga Toxin 2 and Its Variants. J. Clin. Microbiol. 46: 1292-1297 [Abstract] [Full Text]  
• Baker, D. R., Moxley, R. A., Steele, M. B., LeJeune, J. T., Christopher-Hennings, J., Chen, D.-G., Hardwidge, P. R., Francis, D. H. (2007). Differences in Virulence among Escherichia coli O157:H7 Strains Isolated from Humans during Disease Outbreaks and from Healthy Cattle. Appl. Environ. Microbiol. 73: 7338-7346 [Abstract] [Full Text]  
• Vali, L., Hamouda, A., Hoyle, D. V., Pearce, M. C., Whitaker, L. H. R., Jenkins, C., Knight, H. I., Smith, A. W., Amyes, S. G. B. (2007). Antibiotic resistance and molecular epidemiology of Escherichia coli O26, O103 and O145 shed by two cohorts of Scottish beef cattle. J Antimicrob Chemother 59: 403-410 [Abstract] [Full Text]  
• Guth, B. E., Vaz, T. M., Gomes, T. A., Chinarelli, S. H, Rocha, M. M., Pestana de Castro, A. F., Irino, K. (2005). Re-emergence of O103 : H2 Shiga toxin-producing Escherichia coli infections in Sao Paulo, Brazil. J Med Microbiol 54: 805-806 [Full Text]  
• Beutin, L., Kaulfuss, S., Herold, S., Oswald, E., Schmidt, H. (2005). Genetic Analysis of Enteropathogenic and Enterohemorrhagic Escherichia coli Serogroup O103 Strains by Molecular Typing of Virulence and Housekeeping Genes and Pulsed-Field Gel Electrophoresis. J. Clin. Microbiol. 43: 1552-1563 [Abstract] [Full Text]  
• Hussein, H. S., Omaye, S. T. (2003). Introduction to the Food Safety Concerns of Verotoxin-Producing Escherichia coli. Exp. Biol. Med. 228: 331-332 [Abstract] [Full Text]  
• Bettelheim, K. A. (2003). Non-O157 Verotoxin-Producing Escherichia coli: A Problem, Paradox, and Paradigm. Exp. Biol. Med. 228: 333-344 [Abstract] [Full Text]  
• Hussein, H. S., Thran, B. H., Hall, M. R., Kvasnicka, W. G., Torell, R. C. (2003). Verotoxin-Producing Escherichia coli in Culled Beef Cows Grazing Rangeland Forages. Exp. Biol. Med. 228: 352-357 [Abstract] [Full Text]  
• COOKSON, A. L., HAYES, C. M., PEARSON, G. R., ROE, J. M., WALES, A. D., WOODWARD, M. J. (2002). Isolation from a sheep of an attaching and effacing Escherichia coli O115:H- with a novel combination of virulence factors. J Med Microbiol 51: 1041-1049 [Abstract] [Full Text]  
• Siegler, R. L., Pavia, A. T., Sherbotie, J. R. (2002). Recurrent Hemolytic Uremic Syndrome. CLIN PEDIATR 41: 705-709 [Abstract]  
• Johnson, J. R., Jerome, C., Boster, D. R., Stapleton, A. E., Tarr, P. I. (2002). Analysis of Urinary Escherichia coli Isolates for Ability To Produce Shiga Toxin. J. Clin. Microbiol. 40: 2247-2248 [Abstract] [Full Text]  
• Braunstein, J. B., Kershner, D. W., Bray, P., Gerstenblith, G., Schulman, S. P., Post, W. S., Blumenthal, R. S. (2002). Interaction of Hemostatic Genetics With Hormone Therapy : New Insights To Explain Arterial Thrombosis in Postmenopausal Women. Chest 121: 906-920 [Abstract] [Full Text]  
• Eklund, M., Scheutz, F., Siitonen, A. (2001). Clinical Isolates of Non-O157 Shiga Toxin-Producing Escherichia coli: Serotypes, Virulence Characteristics, and Molecular Profiles of Strains of the Same Serotype. J. Clin. Microbiol. 39: 2829-2834 [Abstract] [Full Text]  
• Heczko, U., Carthy, C. M., O'Brien, B. A., Finlay, B. B. (2001). Decreased Apoptosis in the Ileum and Ileal Peyer's Patches: a Feature after Infection with Rabbit Enteropathogenic Escherichia coli O103. Infect. Immun. 69: 4580-4589 [Abstract] [Full Text]  
• Unkmeir, A., Schmidt, H. (2000). Structural Analysis of Phage-Borne stx Genes and Their Flanking Sequences in Shiga Toxin-Producing Escherichia coli and Shigella dysenteriae Type 1 Strains. Infect. Immun. 68: 4856-4864 [Abstract] [Full Text]  
• Tarr, P. I., Bilge, S. S., Vary, J. C. Jr., Jelacic, S., Habeeb, R. L., Ward, T. R., Baylor, M. R., Besser, T. E. (2000). Iha: a Novel Escherichia coli O157:H7 Adherence-Conferring Molecule Encoded on a Recently Acquired Chromosomal Island of Conserved Structure. Infect. Immun. 68: 1400-1407 [Abstract] [Full Text]  
• Oswald, E., Schmidt, H., Morabito, S., Karch, H., Marches, O., Caprioli, A. (2000). Typing of Intimin Genes in Human and Animal Enterohemorrhagic and Enteropathogenic Escherichia coli: Characterization of a New Intimin Variant. Infect. Immun. 68: 64-71 [Abstract] [Full Text]  
• Karch, H., Schubert, S., Zhang, D., Zhang, W., Schmidt, H., Olschlager, T., Hacker, J. (1999). A Genomic Island, Termed High-Pathogenicity Island, Is Present in Certain Non-O157 Shiga Toxin-Producing Escherichia coli Clonal Lineages. Infect. Immun. 67: 5994-6001 [Abstract] [Full Text]  
• Hashimoto, H., Mizukoshi, K., Nishi, M., Kawakita, T., Hasui, S., Kato, Y., Ueno, Y., Takeya, R., Okuda, N., Takeda, T. (1999). Epidemic of Gastrointestinal Tract Infection Including Hemorrhagic Colitis Attributable to Shiga Toxin 1-producing Escherichia coli O118:H2 at a Junior High School in Japan. Pediatrics 103: e2-2 [Abstract] [Full Text]  
• Abe, A., Heczko, U., Hegele, R. G., Brett Finlay, B. (1998). Two Enteropathogenic Escherichia coli Type III Secreted Proteins, EspA and EspB, Are Virulence Factors. JEM 188: 1907-1916 [Abstract] [Full Text]  
• Nataro, J. P., Kaper, J. B. (1998). Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11: 142-201 [Abstract] [Full Text]  
• Acheson, D. W.K., Wolf, L. E., Park, C. H., Rossboth, D. W., Tarr, P. I., Stapleton, A. E., Wilson, R. A., Rondeau, E., Peraldi, M.-N. (1997). Escherichia coli and the Hemolytic-Uremic Syndrome. NEJM 336: 515-516 [Full Text]  
• Rondeau, E., Peraldi, M.-N. (1996). Escherichia coli and the Hemolytic-Uremic Syndrome. NEJM 335: 660-662 [Full Text]